Speech Disorder
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Voiceitt for People With Impairments in Speech
Wireless Implantable Mandarin Chinese Speech Neuroprosthesis Evaluation
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
Neural Changes After Speech Therapy in Patients With Cleft Palate: A Brain Imaging Study
Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication
Characteristics of Idiopathic Familial Speech Disorders
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing